Mike Matson
Stock Analyst at Needham
(3.06)
# 2,465
Out of 5,182 analysts
545
Total ratings
42.34%
Success rate
0.88%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Reiterates: Buy | $58 | $37.72 | +53.76% | 22 | Apr 7, 2026 | |
| VCYT Veracyte | Maintains: Buy | $48 | $33.80 | +42.01% | 20 | Apr 1, 2026 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $101 | $70.93 | +42.39% | 34 | Apr 1, 2026 | |
| BSX Boston Scientific | Reiterates: Buy | $97 | $64.23 | +51.02% | 37 | Mar 30, 2026 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.25 | +140.00% | 23 | Mar 26, 2026 | |
| MDT Medtronic | Reiterates: Buy | $120 | $86.19 | +39.23% | 25 | Mar 26, 2026 | |
| KIDS OrthoPediatrics | Maintains: Buy | $26 → $30 | $16.75 | +79.10% | 25 | Feb 27, 2026 | |
| PSNL Personalis | Maintains: Buy | $10 → $12 | $6.73 | +78.31% | 22 | Feb 27, 2026 | |
| ENOV Enovis | Maintains: Buy | $49 → $52 | $26.32 | +97.57% | 17 | Feb 26, 2026 | |
| TFX Teleflex | Maintains: Buy | $138 → $147 | $131.58 | +11.72% | 11 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $81 | $67.12 | +20.68% | 28 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $166 → $174 | $115.87 | +50.17% | 15 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $86 | $67.08 | +28.21% | 7 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $8.35 | +79.64% | 29 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $29.72 | +51.41% | 36 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $94.78 | - | 27 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $448 → $454 | $343.32 | +32.24% | 11 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $39.08 | - | 26 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $332.13 | - | 14 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $61.62 | - | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.25 → $9 | $3.84 | +134.38% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $14.65 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $6.82 | +75.95% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $178.39 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $129.96 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $225.79 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $228.12 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $14.09 | +198.08% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $95.25 | -21.26% | 1 | Feb 18, 2021 |
Artivion
Apr 7, 2026
Reiterates: Buy
Price Target: $58
Current: $37.72
Upside: +53.76%
Veracyte
Apr 1, 2026
Maintains: Buy
Price Target: $48
Current: $33.80
Upside: +42.01%
Merit Medical Systems
Apr 1, 2026
Reiterates: Buy
Price Target: $101
Current: $70.93
Upside: +42.39%
Boston Scientific
Mar 30, 2026
Reiterates: Buy
Price Target: $97
Current: $64.23
Upside: +51.02%
Lucid Diagnostics
Mar 26, 2026
Reiterates: Buy
Price Target: $3
Current: $1.25
Upside: +140.00%
Medtronic
Mar 26, 2026
Reiterates: Buy
Price Target: $120
Current: $86.19
Upside: +39.23%
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $26 → $30
Current: $16.75
Upside: +79.10%
Personalis
Feb 27, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $6.73
Upside: +78.31%
Enovis
Feb 26, 2026
Maintains: Buy
Price Target: $49 → $52
Current: $26.32
Upside: +97.57%
Teleflex
Feb 26, 2026
Maintains: Buy
Price Target: $138 → $147
Current: $131.58
Upside: +11.72%
Feb 25, 2026
Maintains: Buy
Price Target: $64 → $81
Current: $67.12
Upside: +20.68%
Feb 25, 2026
Maintains: Buy
Price Target: $166 → $174
Current: $115.87
Upside: +50.17%
Feb 24, 2026
Maintains: Buy
Price Target: $84 → $86
Current: $67.08
Upside: +28.21%
Feb 17, 2026
Maintains: Buy
Price Target: $14 → $15
Current: $8.35
Upside: +79.64%
Feb 12, 2026
Reiterates: Buy
Price Target: $45
Current: $29.72
Upside: +51.41%
Feb 10, 2026
Reiterates: Hold
Price Target: n/a
Current: $94.78
Upside: -
Jan 30, 2026
Maintains: Buy
Price Target: $448 → $454
Current: $343.32
Upside: +32.24%
Jan 29, 2026
Reiterates: Hold
Price Target: n/a
Current: $39.08
Upside: -
Jan 16, 2026
Downgrades: Hold
Price Target: n/a
Current: $332.13
Upside: -
Dec 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $61.62
Upside: -
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $3.84
Upside: +134.38%
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.65
Upside: -
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $6.82
Upside: +75.95%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $178.39
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $129.96
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $225.79
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $228.12
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $14.09
Upside: +198.08%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $95.25
Upside: -21.26%